Abstract
This chapter deals with a selection of medical applications of bioinformatics, starting with genetically based diseases and the use of single-nucleotide polymorphisms (SNPs). Infectious and noninfectious diseases are covered. The use of differentially expressed genes (DEGs) is outlined in a number of examples. Genome-wide association studies, as a possible approach to personalized medicine, are critically appraised. Gene-editing is briefly discussed. Automated diagnosis of disease is seen primarily as a problem of pattern recognition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Some would also argue for a preventive role, but the primacy of the curative purpose is indisputable. See Ramsden (2021) for more discussion.
- 2.
- 3.
- 4.
Indeed, one could view the organism as a gigantic hidden Markov model (Sect. 17.5.2), in which the gene controls switching between physiological states via protein expression. Unlike the simpler models considered earlier, here the outputs could intervene in hidden layers.
- 5.
Since the physiological column includes entries for neurophysiological states, it might be tempting to continue the table by adding a column for the conscious experiences corresponding to the physiological and other entries. One must be careful to note, however, that conscious experience is in a different category from the entries in the columns that precede it (Ramsden 2001). Hence, correlation cannot be taken to imply identity (in the same way, a quadratic equation with two roots derived by a piece of electronic hardware is embodied in the hardware, but it makes no sense to say that the hardware has two roots, despite the fact that those roots have well-defined correlates in the electronic states of the circuit components).
- 6.
Mossink et al. (2012).
- 7.
These data can also be used to infer population structures (Jakobsson et al. 2008).
- 8.
These investigations are closely related to those of linkage disequilibrium (nonrandom association between alleles at different loci).
- 9.
Chumakov et al. (2005).
- 10.
There are about ten times more cells in the human microbiome than in the human body proper (cf. Chap. 19), but of course these cells are very small (and their individual genomes are much smaller than that of the human being) and their total mass only amounts to some 2% of human body mass. There is, however, an enormous variety of different microörganisms in the GIT.
- 11.
- 12.
- 13.
Shapiro (1992).
- 14.
An example of the lack of a simple genetic cause of disease is illustrated by the fact that the same mutations affecting the calcium channel protein in nerve cells are observed in patients whose symptoms range from sporadic headaches to partial paralysis lasting several weeks. This is further evidence in favour of Wright’s “many gene, many enzyme” hypothesis as opposed to Beadle and Tatum’s “one gene, one enzyme” idea.
- 15.
**ao et al. (2018).
- 16.
Zhou et al. (2018).
- 17.
Oh et al. (2011).
- 18.
Kim et al. (2013).
- 19.
Cross (2015).
- 20.
Many of these adverse reactions, which are closely related to susceptibility to toxins, can be traced to variation in an individual’s cytochrome P450 enzymes, which are strongly involved in drug metabolism (Zanger and Schwab 2013).
- 21.
These developments are generally referred to as pharmacogenomics.
- 22.
See Risch and Merikangas (1996) for more about the assumptions behind these formulae.
- 23.
Sander and Joung (2014).
- 24.
Conventional gene editing uses homologous recombination (HR). Plants are typically genetically modified (introduction of new genes, deletion of existing genes, alteration of existing genes) by transgenesis, which involves the introduction of a foreign gene into the plant’s genome using gene guns, bacterial vectors or viruses.
- 25.
Murry and Keller (2008).
References
Awdeh ZL, Alper CA (2005) Mendelian inheritance of polygenic diseases: a hypothetical basis for increasing incidence. Med Hypotheses 64:495–498
Awdeh ZL, Yunis EJ, Audeh MJ, Fici D, Pugliese A, Larsen CE, Alper CA (2006) A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease. J Autoimmun 27:174–181
Chumakov S et al (2005) The theoretical basis of universal identification systems for bacteria and viruses. J Biol Phys Chem 5:121–128
Cross D (2015) An unhealthy obsession with fluoride. Nanotechnol Percept 11:169–185
Eckman MH, Greenberg SM, Rosand J (2009) Should we test for CYP2C19 before initiating anticoagulant therapy in patients with atrial fibrillation? J Gen Intern Med 24:543–549
Foster KR, Shaulsky G, Strassman JE, Queller DC, Thompson CRL (2004) Pleiotropy is a mechanism to stabilize cooperation. Nature 431:693–696
Hermsen R, Deris JB, Hwa T (2012) On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient. Proc Natl Acad Sci USA 109:10775–10780
Jakobsson M et al (2008) Genotype, haplotype and copy-number variation in worldwide human populations. Nature 451:998–1003
Kepler TB, Perelson AS (1998) Drug concentration heterogeneity facilitates the evolution of drug resistance. Proc Natl Acad Sci USA 95:11514–11519
Kim H, Lee Y-G, Kim N (2013) Bioinformatics interpretation of exome sequencing: blood cancer. Genomics Inform 11:24–33
Lin J, Wu G, Zhao Z, Huang Y, Chen J, Fu C, Ye J, Liu X (2018) Bioinformatics analysis to identify key genes and pathways influencing synovial inflammation in osteoarthritis. Molec Med Rep 18:5594–5602
Manolio TA, Brooks LD, Collins FS (2008) A HapMap harvest of insights into the genetics of common disease. J Clin Investig 118:1590–1605
Mossink B et al (2012) Human neuronal networks on micro-electrode arrays are a highly robust tool to study disease-specific genotype-phenotype correlations in vitro. Stem Cell Rep 16:2182–2196
Murry CE, Keller G (2008) Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132:661–680
Myers RH (2006) Considerations for genomewide association studies in Parkinson disease. Am J Human Genet 78:1081–1082
Oh JH, Craft JM, Townsend R, Deasy JO, Bradley JD, Naqa IE (2011) A bioinformatics approach for biomarker identification in radiation-induced lung inflammation from limited proteomics data. J Proteome Res 10:1406–1415
Paynter NP et al (2009) Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Internal Med 150:65–72
Pritchard JK, Cox NJ (2002) The allelic architecture of human disease genes: common disease—common variant \(\ldots \) or not? Human Molec Genet 11:2417–2423
Ramsden JJ (2001) Computational aspects of consciousness. Psyche Problem Perspect 1:93–100
Ramsden JJ (2021) Reform of the NHS. J Biol Phys Chem 21:107–118
Risch N, Merikangas K (1996) The future of genetic studies of complex human diseases. Science 273:1516–1517
Sander JD, Joung JK (2014) CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 32:347–355
Shapiro JA (1992) Natural genetic engineering in evolution. Genetica 86:99–111
Summers AO (2002) Generally overlooked fundamentals of bacterial genetics and ecology. Clin Infect Dis 34(Suppl 3):S85–S92
Summers AO (2006) Genetic linkage and horizontal gene transfer, the roots of the antibiotic multi-resistance problem. Anim Biotechnol 17:125–135
Terwilliger JD, Hiekkalinna T (2006) An utter refutation of the ‘Fundamental Theorem of the HapMap’. Eur J Human Genet 14:426–437
Weiss KM, Terwilliger JD (2000) How many diseases does it take to map a gene with SNPs? Nat Genet 26:151–156
**ao H, Bartoszek K, Lio P (2018) Multi-omic analysis of signalling factors in inflammatory comorbidities. BMC Bioinform 19:439
Yang E, Maguire T, Yarmush ML, Berthiaume F, Androulakis IP (2007) Bioinformatics analysis of the early inflammatory response in a rat thermal injury model. BMC Bioinform 8:10
Zanger UM, Schwab M (2013) Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138:103–141
Zhou L-T, Qiu S, Lv L-L, Li Z-L, Liu H, Tang R-N, Ma K-L, Liu B-C (2018) Integrative bioinformatics analysis provides insight into the molecular mechanisms of chronic kidney diseases. Kidney Blood Press Res 43:568–581
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ramsden, J. (2023). Medicine and Disease. In: Bioinformatics. Computational Biology. Springer, Cham. https://doi.org/10.1007/978-3-030-45607-8_26
Download citation
DOI: https://doi.org/10.1007/978-3-030-45607-8_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-45606-1
Online ISBN: 978-3-030-45607-8
eBook Packages: Computer ScienceComputer Science (R0)